Literature DB >> 8714746

Apoptosis induced by microtubule disrupting drugs in normal murine thymocytes in vitro.

V Bumbasirević1, A Skaro-Milić, A Mircić, B Djuricić.   

Abstract

Disruption of cytoplasmic and spindle microtubules by colchicine or nocodazole increases mitotic index, but it also enhances apoptosis in isolated mouse thymocytes; the apoptotic index exceeds 20% after 4 hours of incubation with either drug (5% in controls). Apoptosis was confirmed by DNA fragmentation, and was blocked by calcium chelators and inhibitors of protein synthesis. The apoptotic effect of microtubule disrupting drugs (MDD) was directed to interphase thymocytes and was independent on MDD action on mitotic cells. However, cell death of mitotically arrested cells showed ultrastructural changes similar in many aspects to apoptosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8714746

Source DB:  PubMed          Journal:  Scanning Microsc        ISSN: 0891-7035


  8 in total

1.  T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle.

Authors:  M Karas; T Z Zaks; J L Liu; D LeRoith
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

2.  A high throughput drug screen based on fluorescence resonance energy transfer (FRET) for anticancer activity of compounds from herbal medicine.

Authors:  H Tian; L Ip; H Luo; D C Chang; K Q Luo
Journal:  Br J Pharmacol       Date:  2007-01-18       Impact factor: 8.739

3.  Cell cycle-dependent Cdc25C phosphatase determines cell survival by regulating apoptosis signal-regulating kinase 1.

Authors:  Y-C Cho; J E Park; B C Park; J-H Kim; D G Jeong; S G Park; S Cho
Journal:  Cell Death Differ       Date:  2015-01-30       Impact factor: 15.828

4.  Expressions of tumor necrosis factor-α, its receptor I, II and receptor-associated factor 2 in the porcine corpus luteum during the estrous cycle and early pregnancy.

Authors:  Chie Suzuki; Koji Yoshioka; Manabu Yamada; Toru Miyamoto; Noboru Manabe
Journal:  Vet Res Commun       Date:  2013-09-22       Impact factor: 2.459

5.  Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642).

Authors:  Desirée Hao; Jinee D Rizzo; Stephanie Stringer; Rodney V Moore; Jennifer Marty; Daniel L Dexter; Gina L Mangold; James B Camden; Daniel D Von Hoff; Steven D Weitman
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

6.  Early pathogenesis of the foot-and-mouth disease virus O/JPN/2010 in experimentally infected pigs.

Authors:  Manabu Yamada; Katsuhiko Fukai; Kazuki Morioka; Tatsuya Nishi; Reiko Yamazoe; Rie Kitano; Nobuaki Shimada; Kazuo Yoshida; Toru Kanno; Kenichi Sakamoto; Makoto Yamakawa
Journal:  J Vet Med Sci       Date:  2018-03-06       Impact factor: 1.267

7.  Pathogenesis of the attenuated foot-and-mouth disease virus O/JPN/2000 in experimentally infected pigs.

Authors:  Manabu Yamada; Katsuhiko Fukai; Kazuki Morioka; Tatsuya Nishi; Reiko Yamazoe; Rie Kitano; Nobuaki Shimada; Kazuo Yoshida; Toru Kanno; Kenichi Sakamoto; Makoto Yamakawa
Journal:  J Vet Med Sci       Date:  2018-09-14       Impact factor: 1.267

8.  Activation of PERK Contributes to Apoptosis and G2/M Arrest by Microtubule Disruptors in Human Colorectal Carcinoma Cells .

Authors:  Ming-Shun Wu; Chih-Chiang Chien; Ganbolor Jargalsaikhan; Noor Andryan Ilsan; Yen-Chou Chen
Journal:  Cancers (Basel)       Date:  2019-12-30       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.